In this edition:
-
- Elevated NT-proBNP as a CV disease risk equivalent
- Structural cardiac abnormalities in patients with AF/flutter and myocardial injury
- Subcutaneous vs transvenous ICDs
- Longer-term all-cause and CV mortality after intensive BP control
- Management of patients with recurrent traumatic syncope and bifascicular block
- Single point-of-care hs-cTnI measurement to rule out acute MI
- Once-weekly tirzepatide for the treatment of obesity
- DOACs vs VKAs in patients with thrombotic antiphospholipid syndrome
- Sodium restriction in patients with heart failure
- Impact of BP reduction in patients with isolated diastolic hypertension